332 related articles for article (PubMed ID: 31147751)
1. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease.
Feng YL; Cao G; Chen DQ; Vaziri ND; Chen L; Zhang J; Wang M; Guo Y; Zhao YY
Cell Mol Life Sci; 2019 Dec; 76(24):4961-4978. PubMed ID: 31147751
[TBL] [Abstract][Full Text] [Related]
2. Maternal Adenine-Induced Chronic Kidney Disease Programs Hypertension in Adult Male Rat Offspring: Implications of Nitric Oxide and Gut Microbiome Derived Metabolites.
Hsu CN; Yang HW; Hou CY; Chang-Chien GP; Lin S; Tain YL
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008046
[TBL] [Abstract][Full Text] [Related]
3. Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis.
Chen L; Chen DQ; Liu JR; Zhang J; Vaziri ND; Zhuang S; Chen H; Feng YL; Guo Y; Zhao YY
Exp Mol Med; 2019 Mar; 51(3):1-18. PubMed ID: 30918245
[TBL] [Abstract][Full Text] [Related]
4. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
[TBL] [Abstract][Full Text] [Related]
5. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease.
Wu IW; Gao SS; Chou HC; Yang HY; Chang LC; Kuo YL; Dinh MCV; Chung WH; Yang CW; Lai HC; Hsieh WP; Su SC
Theranostics; 2020; 10(12):5398-5411. PubMed ID: 32373220
[TBL] [Abstract][Full Text] [Related]
6. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity.
Wang H; Ainiwaer A; Song Y; Qin L; Peng A; Bao H; Qin H
Microbiome; 2023 Jan; 11(1):3. PubMed ID: 36624472
[TBL] [Abstract][Full Text] [Related]
7. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
[TBL] [Abstract][Full Text] [Related]
8. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
9. Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review.
Zhao J; Ning X; Liu B; Dong R; Bai M; Sun S
Ren Fail; 2021 Dec; 43(1):102-112. PubMed ID: 33406960
[TBL] [Abstract][Full Text] [Related]
10. Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction.
Wu IW; Lee CC; Hsu HJ; Sun CY; Chen YC; Yang KJ; Yang CW; Chung WH; Lai HC; Chang LC; Su SC
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32932711
[TBL] [Abstract][Full Text] [Related]
11. Lanthanum hydroxide protects kidney through gut microbiota in a rat model of chronic kidney disease.
Gao Y; Wang S; Sun L; Li B; Liu H; Bu R; Su C; Guo M; Liu Y; Zhao L; Gu C; Li X; Yuan X; Wang Q; Li G
Pharmacol Res Perspect; 2024 Apr; 12(2):e1187. PubMed ID: 38546116
[TBL] [Abstract][Full Text] [Related]
12. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
[TBL] [Abstract][Full Text] [Related]
14. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis study of the robustness and universality of gut microbiome-metabolome associations.
Muller E; Algavi YM; Borenstein E
Microbiome; 2021 Oct; 9(1):203. PubMed ID: 34641974
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota, hypertension and chronic kidney disease: Recent advances.
Sircana A; De Michieli F; Parente R; Framarin L; Leone N; Berrutti M; Paschetta E; Bongiovanni D; Musso G
Pharmacol Res; 2019 Jun; 144():390-408. PubMed ID: 29378252
[TBL] [Abstract][Full Text] [Related]
17. Integrated gut microbiota and fecal metabolomics reveal the renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced CKD rats.
Zhang ZM; Yang L; Wan Y; Liu C; Jiang S; Shang EX; Duan JA
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122728. PubMed ID: 33975272
[TBL] [Abstract][Full Text] [Related]
18. Urinary and Fecal Metabonomics Study of the Protective Effect of Chaihu-Shu-Gan-San on Antibiotic-Induced Gut Microbiota Dysbiosis in Rats.
Yu M; Jia HM; Zhou C; Yang Y; Sun LL; Zou ZM
Sci Rep; 2017 Apr; 7():46551. PubMed ID: 28425490
[TBL] [Abstract][Full Text] [Related]
19. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
20. Integrated Analyses of the Gut Microbiota, Intestinal Permeability, and Serum Metabolome Phenotype in Rats with Alcohol Withdrawal Syndrome.
Yang F; Wei J; Shen M; Ding Y; Lu Y; Ishaq HM; Li D; Yan D; Wang Q; Zhang R
Appl Environ Microbiol; 2021 Aug; 87(18):e0083421. PubMed ID: 34190609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
